View source

Selected presentations given at the Drug Information Association (DIA) Annual Meeting in Boston, MA on May 24-26, 2013.

=== Key multiplicity concepts and principles addressed in the draft guidance "Multiple Endpoints in Clinical Trials" ===

Presented by Mohammad Huque, Director, Division of Biometrics IV, Office of Biostatistics, Office of the Translational Sciences, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration.

Download [http://www.multxpert.com/doc/dia2013a.pdf slides].

=== Key multiplicity issues in clinical drug development ===

Presented by Ralph D'Agostino, Boston University.

Slides will be uploaded soon.

=== Analysis of clinical trials with multiple objectives ===

Presented by Alex Dmitrienko, Executive Director, Quintiles.

Download [http://www.multxpert.com/doc/dia2013c.pdf slides].